Physician profile
Gerald R Neidigh
NPI 1841370012
$14,646.81
in general payments reported to CMS, 2019-2025
30 companies · $1,100 in 2025
The $1,100 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,666 · 2020: $944 · 2021: $903 · 2022: $1,156 · 2023: $4,981 · 2024: $2,896 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,100 · Food and Beverage: $2,598 · Consulting Fee: $260 · Entertainment: $19.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,100.00 |
| Food and Beverage | $2,597.65 |
| Consulting Fee | $260.00 |
| Entertainment | $19.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $9,939.47 | 2019-2025 | Dailies Total1, Precision 1, Air Optix Color |
| Johnson & Johnson Vision Care, INC. | $1,103.73 | 2019-2025 | Acuvue |
| Allergan, INC. | $370.12 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $307.03 | 2022-2025 | Blink Nutritears, Infuse, Miebo |
| Abb Con-Cise Optical Group LLC | $233.55 | 2020-2024 | Spectacle Lenses, Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $225.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $225.12 | 2020-2022 | |
| Carl Zeiss Meditec USA, INC. | $205.90 | 2023-2024 | Clarus, Cirrus Hd-Oct |
| Sun Pharmaceutical Industries INC. | $191.31 | 2023-2025 | Bromsite, Xelpros, Cequa |
| Topcon Healthcare, INC. | $176.04 | 2025 | |
| Coopervision INC. | $171.03 | 2021-2025 | Biofinity Contact Lens, Myday Contact Lens |
| Lumibird Medical INC. | $151.98 | 2025 | |
| Biotissue Holdings INC. | $151.02 | 2023-2024 | |
| Abbvie INC. | $137.85 | 2022-2025 | |
| Horizon Therapeutics Plc | $121.95 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $117.59 | 2019 | |
| Lkc Technologies, INC. | $109.73 | 2024 | |
| Oyster Point Pharma, INC. | $103.94 | 2023-2025 | Tyrvaya |
| Maculogix, INC. | $96.69 | 2019-2021 | |
| Sight Sciences, INC. | $77.62 | 2022-2023 | Tearcare System |
| Kala Pharmaceuticals, INC. | $70.28 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $69.83 | 2019-2020 | |
| Optos, INC. | $61.26 | 2021-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Harrow Eye, LLC | $58.47 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $46.48 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $30.00 | 2021 | |
| Mallinckrodt Hospital Products INC. | $28.92 | 2021 | |
| Lombart Brothers, INC. | $24.48 | 2025 | Opd-III |
| Thea Pharma INC. | $20.10 | 2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Neidigh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.